Flash­ing red on RSV ma­ter­nal vac­cine, GSK paus­es PhI­II tri­al fol­low­ing ‘ob­ser­va­tion’ from safe­ty check

Glax­o­SmithK­line is halt­ing three tri­als of its ma­ter­nal RSV vac­cine can­di­date in­volv­ing preg­nant women, in­clud­ing a Phase III, in the wake of a safe­ty sig­nal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER